Drug Trial Radar · NCT00342849
Treatment of Lead-Exposed Children Trial
Last checked: Nov 20, 2026Latest source record: Apr 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
780
Actual
Start
Jul 15, 1994
Primary completion
Aug 29, 2007
Study completion Jun 10, 2015
Sponsor
- Lead sponsor
- National Institute of Environmental Health Sciences (NIEHS)NIH
- Sponsor type
- NIH
- First posted
- Jun 21, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 months, up to 33 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Treatment of Lead-Exposed Children (TLC) clinical trial compared the effect of lead chelation with succimer to placebo therapy. TLC was a randomized, double-blind, placebo-controlled clinical trial with sites in Cincinnati and Columbus, Ohio, Philadelphia, Pennsylvania, Baltimore, Maryland and Newark, New Jersey. The study was designed to test outcomes in IQ, neuropsychological function, behavior, physical growth and blood pressure three years after initiation of treatment. Enrollment was conducted between 1994 and 1997, with completion of the initial three-year follow-up in 2000.
Conditions
- Lead Exposure
Interventions
SuccimerDrug
Succimer (2,3-meso-dimercaptosuccinic acid) is an orally active dithiol compound that is a relatively specific chelating agent for heavy metals, especially lead, arsenic and mercury. The drug undergoes limited absorption in the gastrointestinal tract and then is rapidly metabolized to mixed disulfides which are eliminated in the urine. Blood levels decline slowly with an apparent elimination half-life of about 48 hours in adults.
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- EfficacyTime frame: Annually
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Kennedy Krieger Institute
Baltimore, Maryland
University of Medicine and Dentistry of New Jersey
Newark, New Jersey
Childrens Hospital, Columbus
Columbus, Ohio
Childrens Hospital, Philadelphia
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.